Zhejiang Hisoar Pharmaceutical Co., Ltd. (SHE:002099)
China · Delayed Price · Currency is CNY 5.35
+0.14 (2.69%)
Jun 11, 2026, 3:04 PM CST
SHE:002099 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
| 8,370 | 9,877 | 8,190 | 11,639 | 11,347 | 13,338 | |
Market Cap Growth | 1.41% | 20.59% | -29.63% | 2.57% | -14.93% | -3.06% |
Enterprise Value | 8,599 | 9,669 | 7,823 | 11,071 | 10,844 | 11,966 |
Last Close Price | 5.35 | 6.24 | 5.16 | 7.19 | 6.97 | 8.07 |
PE Ratio | - | - | - | - | 128.93 | 140.06 |
Forward PE | - | 15.91 | 15.91 | 15.91 | 15.91 | 15.91 |
PS Ratio | 4.50 | 5.31 | 4.22 | 5.36 | 4.20 | 5.37 |
PB Ratio | 1.70 | 1.96 | 1.60 | 2.08 | 1.86 | 2.18 |
P/TBV Ratio | 2.07 | 2.38 | 1.94 | 2.60 | 2.34 | 2.74 |
P/FCF Ratio | - | - | 155.34 | 133.07 | - | - |
P/OCF Ratio | - | - | 46.85 | 48.39 | 97.74 | 130.31 |
EV/Sales Ratio | 4.62 | 5.20 | 4.04 | 5.10 | 4.01 | 4.82 |
EV/EBITDA Ratio | 36.00 | 41.53 | 37.85 | 119.42 | 25.23 | 29.45 |
EV/EBIT Ratio | - | - | - | - | 110.50 | 102.12 |
EV/FCF Ratio | - | - | 148.38 | 126.58 | - | - |
Debt / Equity Ratio | 0.22 | 0.26 | 0.24 | 0.19 | 0.16 | 0.10 |
Debt / EBITDA Ratio | 4.59 | 5.42 | 5.84 | 10.86 | 2.30 | 1.44 |
Debt / FCF Ratio | - | - | 23.40 | 12.06 | - | - |
Net Debt / Equity Ratio | 0.05 | -0.02 | -0.06 | -0.06 | -0.08 | -0.20 |
Net Debt / EBITDA Ratio | 1.02 | -0.45 | -1.59 | -3.94 | -1.14 | -3.06 |
Net Debt / FCF Ratio | -1.55 | 0.78 | -6.23 | -4.18 | 7.72 | 9.78 |
Asset Turnover | 0.25 | 0.25 | 0.26 | 0.27 | 0.33 | 0.33 |
Inventory Turnover | 1.68 | 1.76 | 2.12 | 2.20 | 2.01 | 1.96 |
Quick Ratio | 0.68 | 0.84 | 0.91 | 1.04 | 1.05 | 1.39 |
Current Ratio | 1.20 | 1.28 | 1.30 | 1.45 | 1.65 | 1.98 |
Return on Equity (ROE) | -1.50% | -1.85% | -6.22% | -7.20% | 1.41% | 1.57% |
Return on Assets (ROA) | -0.87% | -0.87% | -1.10% | -2.10% | 0.75% | 0.96% |
Return on Invested Capital (ROIC) | -2.01% | -2.12% | -2.62% | -4.93% | 1.60% | 1.95% |
Return on Capital Employed (ROCE) | -2.00% | -2.00% | -2.50% | -4.70% | 1.50% | 1.90% |
Earnings Yield | -0.88% | -0.92% | -4.03% | -3.61% | 0.78% | 0.71% |
FCF Yield | -1.83% | -1.36% | 0.64% | 0.75% | -0.56% | -0.95% |
Dividend Yield | - | - | - | - | 0.72% | 1.24% |
Payout Ratio | - | - | - | - | 222.06% | 56.13% |
Buyback Yield / Dilution | -15.88% | 3.48% | 2.66% | 8.22% | -10.91% | 0.71% |
Total Shareholder Return | -15.88% | 3.48% | 2.66% | 8.22% | -10.19% | 1.95% |